JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mauro Castelli - PhD
- Deputy Editor: Giovanni Blandino - MD, PhD
- Assistant Editor: Silvia Di Agostino - PhD
- Assistant Editor: Sara Donzelli - PhD
- Managing Editor: Alice Castelli - PhD
Journal of Experimental & Clinical Cancer Research (JECCR) is the official scientific journal of the "Regina Elena" National Cancer Institute since 1986 which publishes manuscripts regarding significant advances in basic cancer research and offers a translational bridge from the laboratory to the clinic.
The most important aims are to open new roads for the understanding, prevention, diagnosis and treatment of cancer and to share the scientific results with the international scientific community.
JECCR has led its editorial activity by maintaining its partnership with the publisher BioMed Central - Springer Nature in London.
Thanks to its “open access” version, JECCR improved its performance in terms of rapid publication of the articles, better widespread all scientific results and higher visibility in the scientific community confirming its position in the 1st quartile among International Oncology Journals
In 2021 JECCR has launched a new Special Issue regarding the latest highlights on drugging cancer vulnerabilities toward innovative clinical trial.
The main accomplishments achieved by JECCR in 2021 are:
- Impact Factor 11.161;
- 2,059,766 downloads;
- 2758 submissions;
- 342 published papers;
Most of submitted and published articles in the last years comes from International Oncology Institutes and Universities worldwide.
The “Journal of Experimental & Clinical Cancer Research” has reinforced its visibility in the international scientific community sharing the latest articles and collections by Social Media. JECCR online website: https://jeccr.biomedcentral.com/
- Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
By: Bin Wang, Qin Zhao, Yuyu Zhang, Zijing Liu, Zhuangzhuang Zheng, Shiyu Liu, Lingbin Meng, Ying Xin and Xin Jiang
Volume: 40 Issue: 2 Article Number: 24 Published: JAN 9 2021 Times Cited: 27 - Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
By: Hao Zhang, Ziyu Dai, Wantao Wu, Zeyu Wang, Nan Zhang, Liyang Zhang, Wen-Jing Zeng, Zhixiong Liu and Quan Cheng
Volume: 40 Issue: 1 Article Number: 184 Published: JUN 4 2021 Times Cited: 22 - LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
By: Lou, Guohua; Chen, Liang; Xia, Caixia; et al.
Volume: 40 Issue: 1 Article Number: 52 Published: FEB 1 2021 Times Cited: 20 - Noncoding RNAs regulate alternative splicing in Cancer
By: Yunze Liu, Xin Liu, Changwei Lin, Xianhong Jia, Hongmei Zhu, Jun Song and Yi Zhang
Volume: 40 Issue: 1 Article Number: 11 Published: JAN 6 2021 Times Cited: 16 - Pyroptosis: a new paradigm of cell death for fighting against cancer
By: Yixin Tan, Quanzhu Chen, Xiaoling Li, Zhaoyang Zeng, Wei Xiong, Guiyuan Li, Xiayu Li, Jianbo Yang, Bo Xiang and Mei Yi
Volume: 40 Issue: 1 Article Number: 153 Published: MAY 3 2021 Times Cited: 13